Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam vs. Desflurane in Lumbar Fusion Surgery
NCT04983966Completed
- Sponsor
- Gangnam Severance Hospital
- Start
- Aug 2021
- Primary completion
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of remimazolam (2 arms), sponsored by Gangnam Severance Hospital. Primary endpoint: Quality of Recovery-15. Started Aug 2021; status: completed.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT04983966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04983966.